Li Y, Wu X
Front Cell Infect Microbiol. 2025; 14:1483544.
PMID: 39897478
PMC: 11782028.
DOI: 10.3389/fcimb.2024.1483544.
Sebutsoe X, Tsotetsi N, Jantjies Z, Raphela-Choma P, Choene M, Motadi L
Onco Targets Ther. 2024; 17:785-801.
PMID: 39345275
PMC: 11439348.
DOI: 10.2147/OTT.S475132.
Cao Y, Peng Y, Tang Y
J Gynecol Oncol. 2024; 36(1):e11.
PMID: 38991944
PMC: 11790996.
DOI: 10.3802/jgo.2025.36.e11.
Luckett R, Ramogola-Masire D, Harris D, Gompers A, Gaborone K, Mochoba L
Front Glob Womens Health. 2024; 4:1300788.
PMID: 38259634
PMC: 10800890.
DOI: 10.3389/fgwh.2023.1300788.
Kajabwangu R, Ssedyabane F, Tusubira D, Maling S, Kakongi N, Turyakira E
Cureus. 2023; 15(10):e46542.
PMID: 37927695
PMC: 10625478.
DOI: 10.7759/cureus.46542.
Global, regional and national burden, incidence, and mortality of cervical cancer.
Momenimovahed Z, Mazidimoradi A, Maroofi P, Allahqoli L, Salehiniya H, Alkatout I
Cancer Rep (Hoboken). 2022; 6(3):e1756.
PMID: 36545760
PMC: 10026270.
DOI: 10.1002/cnr2.1756.
Epidemiological trends of female breast and gynecologic cancers in adolescents and young adults in China from 1990 to 2019: Results from the Global Burden of Disease Study 2019.
Zhao Y, Qiu P, Yan L, Li S, Yang Z, Zhang H
Front Oncol. 2022; 12:1003710.
PMID: 36313685
PMC: 9606349.
DOI: 10.3389/fonc.2022.1003710.
Mapping Evidence on the Burden of Breast, Cervical, and Prostate Cancers in Sub-Saharan Africa: A Scoping Review.
Musekiwa A, Moyo M, Mohammed M, Matsena-Zingoni Z, Twabi H, Batidzirai J
Front Public Health. 2022; 10:908302.
PMID: 35784211
PMC: 9246362.
DOI: 10.3389/fpubh.2022.908302.
HIF-1 Regulates the Progression of Cervical Cancer by Targeting YAP/TAZ.
Abudoukerimu A, Hasimu A, Abudoukerimu A, Tuerxuntuoheti G, Huang Y, Wei J
J Oncol. 2022; 2022:3814809.
PMID: 35664561
PMC: 9159877.
DOI: 10.1155/2022/3814809.
Awareness and Knowledge of HPV, HPV Vaccination, and Cervical Cancer among an Indigenous Caribbean Community.
Warner Z, Reid B, Auguste P, Joseph W, Kepka D, Warner E
Int J Environ Res Public Health. 2022; 19(9).
PMID: 35565089
PMC: 9105034.
DOI: 10.3390/ijerph19095694.
Prognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma.
Wen F, Ruan S, Huang W, Chen X, Wang Y, Gu S
Front Med (Lausanne). 2021; 8:755657.
PMID: 34859010
PMC: 8631969.
DOI: 10.3389/fmed.2021.755657.
Epidemiology of HPV Related Malignancies.
Scott-Wittenborn N, Fakhry C
Semin Radiat Oncol. 2021; 31(4):286-296.
PMID: 34455984
PMC: 9057013.
DOI: 10.1016/j.semradonc.2021.04.001.
Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis.
Bonjour M, Charvat H, Franco E, Pineros M, Clifford G, Bray F
Lancet Public Health. 2021; 6(7):e510-e521.
PMID: 33864738
PMC: 8225515.
DOI: 10.1016/S2468-2667(21)00046-3.
MicroRNA-221 inhibits human papillomavirus 16 E1-E2 mediated DNA replication through activating SOCS1/Type I IFN signaling pathway.
Lu H, Gu X
Int J Clin Exp Pathol. 2020; 12(5):1518-1528.
PMID: 31933969
PMC: 6947112.
Forgone Health and Economic Benefits Associated with Socioeconomic Differences in Organized Cervical Cancer Screening.
Hsieh V, Chen Z, Liu C, Chiang J, Shieh S, Hsieh M
Asian Pac J Cancer Prev. 2019; 20(12):3755-3762.
PMID: 31870118
PMC: 7173370.
DOI: 10.31557/APJCP.2019.20.12.3755.
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.
Arbyn M, Weiderpass E, Bruni L, de Sanjose S, Saraiya M, Ferlay J
Lancet Glob Health. 2019; 8(2):e191-e203.
PMID: 31812369
PMC: 7025157.
DOI: 10.1016/S2214-109X(19)30482-6.
Assessment of the scale-up of cervical cancer screening in Abidjan stratified by HIV status.
Boni S, Tchounga B, Comoe K, Guie P, Adie M, Horo A
Int J Gynaecol Obstet. 2019; 147(2):246-251.
PMID: 31482577
PMC: 6922051.
DOI: 10.1002/ijgo.12959.
Key Molecular Events in Cervical Cancer Development.
Balasubramaniam S, Balakrishnan V, Oon C, Kaur G
Medicina (Kaunas). 2019; 55(7).
PMID: 31319555
PMC: 6681523.
DOI: 10.3390/medicina55070384.
Re-thinking breast and cervical cancer preventive campaigns in developing countries: the case for interventions at high schools.
Ifediora C
BMC Public Health. 2019; 19(1):503.
PMID: 31053073
PMC: 6500011.
DOI: 10.1186/s12889-019-6890-2.
Expression of Micro-RNA-492 (MiR-492) in Human Cervical Cancer Cell Lines is Upregulated by Transfection with Wild-Type P53, Irradiation, and 5-Fluorouracil Treatment In Vitro.
Liu M, Wang Z, Liu Q, Zhu H, Xu N
Med Sci Monit. 2018; 24:7750-7758.
PMID: 30374014
PMC: 6354641.
DOI: 10.12659/MSM.911585.